Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer-Reference-Cited by-同舟云学术

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer

Published:2009-08-21 Issue:22 Volume:115 Page:5309-5318
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Meng Zhiqiang,Yang Peiying,Shen Yehua,Bei Wenying,Zhang Ying,Ge Yongqian,Newman Robert A.,Cohen Lorenzo,Liu Luming,Thornton Bob,Chang David Z.,Liao Zongxing,Kurzrock Razelle

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24602/fullpdf

Reference29 articles.

1. Chan su;Yan;Chin Mater Med,1979

2. Evaluation of pharmacodynamic effect of pharmaceutical agents of Chan Su;Su;J Beijing Univ TCM,2001

3. HPLC separation and determination of bufadienolide in cinobufacini injection;Su;Chin Tradit Pat Med,2003

4. Cardiac glycosides as novel cancer therapeutic agents;Newman;Mol Interv,2008

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway;Journal of Ethnopharmacology;2024-02

2. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression;Heliyon;2024-02

3. Mechanisms underlying the therapeutic effects of cinobufagin in treating melanoma based on network pharmacology, single-cell RNA sequencing data, molecular docking, and molecular dynamics simulation;Frontiers in Pharmacology;2024-01-29

4. Identification of anti-tumor constituents from toad skin and toad venom by UPLC-QTOF/MS in-depth chemical profiling combined with bioactivity-based molecular networking;Arabian Journal of Chemistry;2024-01

5. Research Status of Anti-Aging Drugs in Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024